TP53 and head and neck squamous cell carcinoma: In HNSCC, Pifer et al. found that the FAK inhibitor increased sensitivity to radiation, enhanced DNA damage, and suppressed homologous recombination and nonhomologous end joining repair in the TP53 mutant, but not wild-type, HPV-negative HNSCC cell lines.